fulvestrant has been researched along with dihydrotestosterone in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 15 (71.43) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellavance, E; Luu-The, V; Poirier, D | 1 |
| Arias, DA; Barbieri, LR; Berrodin, TJ; Bigelis, R; Chang, LP; Luckman, SW; McDonald, LA; Roll, DM; Singh, MP; Yudt, MR | 1 |
| Carruba, G; Castagnetta, LA; Comito, L; D'Amico, D; Farruggio, R; Miceli, D; Montesanti, A; Polito, L | 1 |
| Christian, M; Gillies, G | 1 |
| Damien, E; Lanyon, LE; Price, JS | 1 |
| Appa Rao, KB; Gui, Y; Lessey, BA; Lovely, LP | 1 |
| Klinga, K; Mayer, D; Morfin, R; Schmitt, M; Schnarr, B | 1 |
| Chen, Q; Chihara, K; Kaji, H; Sugimoto, T | 1 |
| Chaudhuri, G; Dinh, H; Mukherjee, TK; Nathan, L | 1 |
| Diamandis, EP; Grass, L; Luo, LY | 1 |
| Bobseine, K; Gray, LE; Wilson, VS | 1 |
| Andò, S; Briand, PA; Carpino, A; Fasanella, G; Maggiolini, M; Pezzi, V; Picard, D; Rago, V; Recchia, AG; Vivacqua, A | 1 |
| Carlsten, H; Erlandsson, MC; Gustafsson, JA; Hasséus, B; Islander, U; Jochems, C; Lindberg, M; Ohlsson, C; Skrtic, SM | 1 |
| Childs, GV; Iruthayanathan, M; Zhou, YH | 1 |
| Bland, KI; Chaudry, IH; Choudhry, MA; Hsieh, YC; Schwacha, MG; Yang, S; Yu, HP | 1 |
| Luo, W; Wiltbank, MC | 1 |
| Huhtaniemi, I; Mäkelä, S; Pakarainen, T; Poutanen, M; Savolainen, S | 1 |
| Corey, E; Hess, D; Kalhorn, T; Montgomery, B; Nelson, PS; Vessella, R | 1 |
| Espallergues, J; Laruelle, C; Maurice, T; Temsamani, J; Urani, A | 1 |
| Aubé, M; Ayotte, P; Larochelle, C | 1 |
| Braden, TD; Bruinton, S; Goyal, HO; Okumu, LA; Simon, L | 1 |
21 other study(ies) available for fulvestrant and dihydrotestosterone
| Article | Year |
|---|---|
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
The lecanindoles, nonsteroidal progestins from the terrestrial fungus Verticillium lecanii 6144.
Topics: Animals; Chlorocebus aethiops; Female; Humans; Hypocreales; Indoles; Luciferases; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Progestins; Receptors, Progesterone; Sesquiterpenes | 2009 |
Sex steroids up-regulate E-cadherin expression in hormone-responsive LNCaP human prostate cancer cells.
Topics: Androgen Antagonists; Cadherins; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Flutamide; Fulvestrant; Gonadal Steroid Hormones; Humans; Immunoblotting; Immunohistochemistry; Male; Prostatic Neoplasms | 1995 |
Developing hypothalamic dopaminergic neurones as potential targets for environmental estrogens.
Topics: Analysis of Variance; Animals; Benztropine; Cells, Cultured; Cytarabine; Dihydrotestosterone; Dopamine; Dose-Response Relationship, Drug; Estradiol; Estradiol Congeners; Estrogen Antagonists; Fulvestrant; gamma-Aminobutyric Acid; Hypothalamus; Neuroglia; Neurons; Phenols; Rats; Receptors, Dopamine; Receptors, Estrogen; Time Factors; Xenobiotics | 1999 |
Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females.
Topics: Androgen Antagonists; Androstenedione; Animals; Antibodies; Aromatase Inhibitors; Cells, Cultured; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens; Flutamide; Fulvestrant; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Osteoblasts; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Stress, Mechanical; Tamoxifen; Testosterone; Thymidine | 2000 |
Characterization of androgen receptors in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa).
Topics: Adenocarcinoma; Alkaline Phosphatase; Androgens; Cell Differentiation; Cell Nucleus; Diethylstilbestrol; Dihydrotestosterone; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Flutamide; Fulvestrant; Humans; Metribolone; Progesterone; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2000 |
Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol.
Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Chromatography, Thin Layer; Dehydroepiandrosterone; Dexamethasone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immunoassay; Mitogens; Tamoxifen; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 2001 |
Testosterone inhibits osteoclast formation stimulated by parathyroid hormone through androgen receptor.
Topics: Androgen Antagonists; Androstenedione; Animals; Aromatase Inhibitors; Cell Division; Cells, Cultured; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Flutamide; Fulvestrant; Glucuronates; Mice; Mice, Inbred ICR; Osteoclasts; Parathyroid Hormone; Receptors, Androgen; Teriparatide; Testosterone | 2001 |
Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis.
Topics: Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Arteriosclerosis; Cell Adhesion; Dihydrotestosterone; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Gene Expression Regulation; Humans; Male; Mice; Nitriles; Receptors, Estrogen; RNA, Messenger; Testosterone; Triazoles; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2002 |
Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Topics: Aldosterone; Androgen Antagonists; Cell Line; Cell Line, Tumor; Chloramphenicol O-Acetyltransferase; Cloning, Molecular; Dexamethasone; Dihydrotestosterone; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Imidazoles; Kallikreins; Kinetics; Mifepristone; Nitriles; Norgestrel; Promoter Regions, Genetic; Recombinant Fusion Proteins; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Up-Regulation | 2003 |
Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
Topics: Breast Neoplasms; Cell Line; Cloning, Molecular; Dexamethasone; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Estrogens, Non-Steroidal; Female; Fulvestrant; Genes, Reporter; Humans; Ligands; Light; Luciferases; Luminescent Measurements; Plasmids; Receptors, Estrogen; TATA Box; Transfection | 2004 |
Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells.
Topics: Androgen Antagonists; Androgens; Anilides; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Fulvestrant; Genes, Reporter; Humans; Male; Nitriles; Oligonucleotides, Antisense; Prostatic Neoplasms; Receptors, Androgen; Response Elements; Tosyl Compounds | 2004 |
Estren promotes androgen phenotypes in primary lymphoid organs and submandibular glands.
Topics: Animals; Bone Marrow; Cell Count; Dihydrotestosterone; Estradiol; Estrenes; Estrogen Receptor Modulators; Female; Fulvestrant; Lymphoid Tissue; Lymphopoiesis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Orchiectomy; Organ Specificity; Ovariectomy; Phenotype; Receptors, Androgen; Receptors, Estrogen; Sex Characteristics; Submandibular Gland; Thymus Gland | 2005 |
Dehydroepiandrosterone restoration of growth hormone gene expression in aging female rats, in vivo and in vitro: evidence for actions via estrogen receptors.
Topics: Aging; Aminoglutethimide; Animals; Aromatase Inhibitors; Cells, Cultured; Dehydroepiandrosterone; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression; Growth Hormone; Pituitary Gland; Rats; Receptors, Estrogen; Receptors, Neuropeptide; Receptors, Pituitary Hormone-Regulating Hormone; RNA, Messenger | 2005 |
Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1.
Topics: Abdominal Injuries; Animals; Aromatase; Dihydrotestosterone; Electron Transport Complex IV; Estradiol; Estrogen Antagonists; Flutamide; Fulvestrant; Heart Function Tests; Hemorrhage; Male; Myocardium; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Testosterone; Transcription Factors; Up-Regulation | 2006 |
Distinct regulation by steroids of messenger RNAs for FSHR and CYP19A1 in bovine granulosa cells.
Topics: Analysis of Variance; Anilides; Animals; Aromatase; Cattle; Cells, Cultured; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Follicle Stimulating Hormone; Fulvestrant; Gene Expression Regulation; Granulosa Cells; Nitriles; Receptors, Androgen; Receptors, FSH; RNA, Messenger; Steroids; Testosterone; Tosyl Compounds | 2006 |
Delay of postnatal maturation sensitizes the mouse prostate to testosterone-induced pronounced hyperplasia: protective role of estrogen receptor-beta.
Topics: Animals; Aromatase Inhibitors; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Fulvestrant; Humans; Hyperplasia; Inflammation; Ki-67 Antigen; Male; Mice; Mice, Knockout; Nitriles; Phosphoproteins; Prolactin; Prostate; Receptors, Androgen; Receptors, LH; Receptors, Progesterone; Testosterone; Trans-Activators; Triazoles | 2007 |
Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Fulvestrant; Humans; Male; Mass Spectrometry; Mice; Mice, SCID; Orchiectomy; Prostatic Neoplasms; Receptors, Estrogen; Testosterone; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
The antidepressant-like effect of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane involves a regulation of β-type estrogen receptors.
Topics: 3-Hydroxysteroid Dehydrogenases; Adrenal Glands; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyanoketone; Dihydrotestosterone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Fulvestrant; Hippocampus; Male; Mice; Motor Activity; RNA, Messenger; Swimming; Time Factors; Up-Regulation | 2011 |
Differential effects of a complex organochlorine mixture on the proliferation of breast cancer cell lines.
Topics: Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Humans; Hydrocarbons, Chlorinated; Neoplasms, Hormone-Dependent; Receptors, Androgen; Regression Analysis | 2011 |
Estrogen-induced maldevelopment of the penis involves down-regulation of myosin heavy chain 11 (MYH11) expression, a biomarker for smooth muscle cell differentiation.
Topics: Actins; Animals; Animals, Newborn; Biomarkers; Cell Differentiation; Diethylstilbestrol; Dihydrotestosterone; Down-Regulation; Estradiol; Fulvestrant; Immunohistochemistry; Male; Myocytes, Smooth Muscle; Myosin Heavy Chains; Penis; Rats; Receptors, Androgen; Receptors, Estrogen; RNA, Messenger; Testis; Testosterone | 2012 |